Gena Huang1, Man Li2. 1. Department of Seven-year Clinical Medicine, Research Institute of Integrated Traditional and Western Medicine of Dalian Medical University Dalian 116044, China. 2. Department of Oncology, Second Hospital of Dalian Medical University Dalian 116023, China.
Abstract
OBJECTIVE: to investigate the role of EphB4 and IGF-1R in the proliferation and migration of breast cancer. METHODS: The relative mRNA levels of EphB4 were measured by RT-PCR. The proliferation of the cells was determined by MTT assay, and cells migration and invasive ability was analyzed using the scratch migration assay. RESULTS: The expression of EphB4 in control group was significantly decreased when compared with IGF-I group (P<0.001). The expression of EphB4 in IGF-I+LY and LY group were lower than that of the control group (P<0.001).The cell proliferation and migration ability of the cells in IGF-I group increased significantly compared to the cells in the control group (P<0.001), while the cells in IGF-1+LY group and LY group showed a decreased proliferation and migration ability compared to the control group (P<0.001). CONCLUSION: IGF-IR might be a upstream gene of EphB4. Besides, higher expression of EphB4 shows increased tumor proliferation and migration in breast cells. The study of EphB4 upstream gene and signaling pathway can provide more targeted anti-tumor point selection for targeted therapy.
OBJECTIVE: to investigate the role of EphB4 and IGF-1R in the proliferation and migration of breast cancer. METHODS: The relative mRNA levels of EphB4 were measured by RT-PCR. The proliferation of the cells was determined by MTT assay, and cells migration and invasive ability was analyzed using the scratch migration assay. RESULTS: The expression of EphB4 in control group was significantly decreased when compared with IGF-I group (P<0.001). The expression of EphB4 in IGF-I+LY and LY group were lower than that of the control group (P<0.001).The cell proliferation and migration ability of the cells in IGF-I group increased significantly compared to the cells in the control group (P<0.001), while the cells in IGF-1+LY group and LY group showed a decreased proliferation and migration ability compared to the control group (P<0.001). CONCLUSION:IGF-IR might be a upstream gene of EphB4. Besides, higher expression of EphB4 shows increased tumor proliferation and migration in breast cells. The study of EphB4 upstream gene and signaling pathway can provide more targeted anti-tumor point selection for targeted therapy.
Authors: Nai-Ying Yang; Pablo Lopez-Bergami; James S Goydos; Dana Yip; Ameae M Walker; Elena B Pasquale; Iryna M Ethell Journal: Pigment Cell Melanoma Res Date: 2010-07-23 Impact factor: 4.693
Authors: Whitney A Spannuth; Lingegowda S Mangala; Rebecca L Stone; Amy R Carroll; Masato Nishimura; Mian M K Shahzad; Sun-Joo Lee; Myrthala Moreno-Smith; Alpa M Nick; Ren Liu; Nicholas B Jennings; Yvonne G Lin; William M Merritt; Robert L Coleman; Pablo E Vivas-Mejia; Yue Zhou; Valery Krasnoperov; Gabriel Lopez-Berestein; Parkash S Gill; Anil K Sood Journal: Mol Cancer Ther Date: 2010-08-03 Impact factor: 6.261
Authors: Alyssa C Taylor; Thomas A Mendel; Katelyn E Mason; Katherine E Degen; Paul A Yates; Shayn M Peirce Journal: Invest Ophthalmol Vis Sci Date: 2012-08-13 Impact factor: 4.799
Authors: G Berclaz; E Karamitopoulou; L Mazzucchelli; V Rohrbach; E Dreher; A Ziemiecki; A-C Andres Journal: Ann Oncol Date: 2003-02 Impact factor: 32.976